Delivery Order SPE2DB20D3103-SPE2DB24FM8J1

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $4.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,554.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) to provide LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the DLA. The contract has a period of performance ending on February 6, 2024 and is a Firm Fixed Price (FFP) agreement. There is no set-aside designation for this award, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of a pharmaceutical product, specifically LIDOCAINE 5% PATCH 30S, with a ceiling value of $12,245.45. The contract was awarded on December 4, 2023, with a final completion date of December 5, 2023. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract does not...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,612.01 Firm Fixed Price Delivery Order is for the provision of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LIDOCAINE 5% PATCH 30S medical products. The contract, valued at $1,194.02, is a firm fixed-price delivery order with a completion date of November 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4559719353 - LIDOCAINE 5% PATCH 30S. The Firm Fixed Price delivery order, valued at $3,700.80, has an ultimate completion date of January 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,280.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,853.09 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The award has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly for the Department of Defense (DoD)...
This federal contract award, valued at $14,614.74, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4554257218 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a completion date of July 29, 2021. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, valued at $1,769.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a for-profit organization. The contract is a Delivery Order under an...
This federal contract award, with ID SPE2DX15D3005|SPE2DX23F3RCY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,091.93 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a completion date of May 3, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM8J1
    Delivery Order

This federal contract award, valued at $4,144.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price type and covers the procurement of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of February 28, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 9:46 AM